Biotech Startups
9,920 companies tagged Biotech, with their investors and founders.
SafeTraces develops technology to measure and verify indoor air quality and ventilation performance, aimed at ensuring air safety in indoor environments. The company applies scientific methods to assess and improve air quality standards for building and facility safety.
2 investors
Saladax Biomedical develops blood-level tests that help psychiatrists and oncologists determine correct individual drug dosages based on patient metabolism, supporting treatment decisions and reducing toxicity risk. It also partners with pharmaceutical companies to create tests for clinical trials and companion diagnostics.
2 investors
Decoy Therapeutics is a biotechnology company developing Designable Multi-Antivirals (D-MAVs), peptide conjugate antivirals built on its AI-enabled IMP³ACT platform to target viral mechanisms conserved across multiple viruses. Its lead programs are inhaled, self-administered fusion inhibitors for respiratory viruses, including a pan-coronavirus treatment for immunocompromised patients and a combined flu/COVID/RSV antiviral.
2 investors
Sampling Human develops systems to generate actionable insights from individual biology using cellular-resolution data collection technologies. The company combines platform engineering, machine learning, diagnostics, and genomics commercialization expertise.
2 investors
Samsara Therapeutics develops small-molecule therapeutics that activate autophagy to slow the progression of age-related neurodegenerative diseases such as ALS, Parkinson's, and Charcot-Marie-Tooth disease. It runs an in-house phenotypic screening platform using patient-derived iPSCs to identify and validate autophagy activators for drug discovery.
2 investors
Samsara BioCapital is a venture capital firm that invests in therapeutic and biotech companies, backing scientific teams developing new drugs and medical treatments.
2 investors
SanegeneBio is a biotech company developing RNA interference (RNAi) genetic medicines for obesity, cardiometabolic, and autoimmune diseases. Its LEAD (Ligand and Enhancer Assisted Delivery) platform enables tissue-specific gene silencing in the liver, adipose tissue, muscle, and immune cells via subcutaneous dosing.
2 investors
Sanodyne Therapeutics develops SNT-001, an orally administered small-molecule compound intended to treat peripheral neuropathy and neuropathic pain. The drug uses a distinct mechanism of action and is positioned as a potential root-cause therapy for pain.
2 investors
2 investors
Sarepta develops precision genetic medicines for people with rare diseases, with a focus on rare neuromuscular conditions. The company also runs an investigator-initiated studies program that funds independent clinical and non-clinical research in its therapeutic areas.
2 investors
Satsuma Pharmaceuticals develops therapeutics for the acute treatment of migraine, including an approved dihydroergotamine nasal powder product (Atzumi/STS101). The company's SMART (Simple MucoAdhesive Release Technology) drug-delivery platform aims to address efficacy and administration limitations of existing migraine treatment formulations.
2 investors
SavranTech is a diagnostics company developing non-invasive, cell-based diagnostic tests for women's health, starting with preeclampsia, and spanning maternal health, prenatal care, and oncology. Its patented platform serves clinicians and healthcare in the women's health diagnostics category.
2 investors
Scala Biodesign develops computational protein design software (ScalaOS) that combines atomistic modeling, evolutionary data, and AI to optimize enzymes, antibodies, therapeutic proteins, and antigens in a single design round. It serves biotechnology and biopharmaceutical companies working on areas such as biocatalysts, biologics, and vaccines.
2 investors
ScienceMachine provides automated quality control for clinical and scientific study documentation, checking reports against protocols and source data to identify missing files and data discrepancies. The platform reconciles study records, calculations, and findings across multiple document formats and integrates with laboratory information systems.
2 investors
Scindo uses AI and machine learning to discover and design novel enzymes for sustainable manufacturing. The company targets cosmetics, personal care, and food product manufacturers seeking to replace conventional chemistry with bio-based alternatives that reduce energy use, waste, and fossil fuel dependence.
2 investors
Scoop converts scientific and manufacturing data into dynamic regulatory documents for drug submissions, using AI to continuously reconcile updates and maintain consistency across filings for pharmaceutical companies and regulatory teams.
2 investors
SCYNEXIS develops fungerp-based antifungal therapies, including SCY-247, for treating and preventing severe, progressive, and often fatal fungal diseases and antimicrobial-resistant infections. The company focuses on rare diseases affecting underserved patient populations.
2 investors
Sea6 Energy develops seaweed-derived biotechnology products and biomaterials for agriculture, animal health, food ingredients, and bioplastics, leveraging ocean farming and bioprocessing technologies. The company operates research facilities, manufacturing units, and processing operations across India and Indonesia.
2 investors
Seal provides a software platform that replaces paper and legacy systems for managing GxP (good manufacturing and laboratory practices) work, with built-in AI assistance for process improvement, validation tracking, and compliance records in pharmaceutical and life sciences manufacturing.
2 investors
Sealonix develops hemostatic sealants based on proprietary biomaterials to control surgical bleeding, targeting surgeons and patients undergoing abdominopelvic and other surgical procedures. Its initial product, the PramStat patch, is an experimental sealant patch for rapid hemostasis during surgery.
2 investors
Seaqure Labs develops mycelium-based protein for animal feed, designed as a sustainable alternative to soy and conventional proteins. The product reduces carbon emissions, water use, and land use significantly while utilizing industrial byproducts in a circular production process.
2 investors
Seascape Clinical provides clinical operations software designed specifically for small and mid-sized biopharma companies, offering streamlined contracting, business case creation, and requirements gathering. The platform prioritizes ease of deployment and integration for resource-constrained biotech teams.
2 investors
AkriVita manufactures 3D-printed microcapillary needles designed to improve precision and reliability in biomedical research, genetic research, biotechnology, and fertility treatments. The company serves biomedical scientists and healthcare professionals conducting research, disease prevention modeling, and therapeutic delivery.
2 investors
Seismic Therapeutic is a clinical-stage biotechnology company that uses machine learning to discover and develop immunology therapies for autoimmune diseases. The company develops a pipeline of biologics derived from its IMPACT platform to control dysregulated adaptive immunity.
2 investors